Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › DRREDDY

DRREDDY

Dr. Reddy's Laboratories Limited
Large-capPharma ↗

What the six lenses say about DRREDDY — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1269.5
2026-07-10
VWAP · 1Y anchor
₹1270
-0.0% from VWAP
P/E · TTM
25.2×
TTM EPS ₹50.3
52-week range
51%
position low→high
RSI(14)
39
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How DRREDDY’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
4.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Large-cap cohortDRaw
TechnicalD778›

The actual numbers

Price vs VWAP (1y)-0.0%
EMA trend stackUp · 21>50>200
Price vs 200-EMA-0.5%
Price vs 50-EMA-2.9%
RSI(14)39
RS vs Nifty 500 · 3M-0.3%
RS vs sector · 3M-12.7%
52-week range51%
Volume vs 30d avg3.68×
Volume vs 60d avg3.07×
ATR(14) · volatility43.6
Bollinger width · vol contraction0.120
FundamentalD241›

The actual numbers

Return on equity (ROE)11.8%
Return on capital (ROCE)13.6%
Operating margin17.1%
Net margin12.3%
Revenue growth · YoY+3.2%
EPS growth · YoY-62.7%
Debt / equity0.20×

Full 8-quarter history in the financials table below.

ValuationD739›

The actual numbers

P/E (TTM)25.2×
TTM EPS₹50.3
52-week range51%
CatalystD546›

The actual numbers

Earnings & momentum50
Capital actions13
Governance153

Every filing in the corporate-announcements panel below.

FlowD142›

The actual numbers

Promoter holding26.6%
Delivery · 30d avg50.4%
Up/down-day asymmetry-4.5pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Large-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D7 + D1 ) ÷ 2 = 4.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
74
Conviction score 74/100 · avg-decile strength 4.0/10
Conviction score74/100›
TechnicalD7›
FundamentalD2›
ValuationD7›
CatalystD5›
FlowD1›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-6.2pp
-4.8pp
-3.4pp
+3.4pp
+11.6pp
+6.0pp
Nifty 500
Broad-market baseline
-6.6pp
-4.9pp
-4.0pp
-0.3pp
+6.6pp
+2.2pp
Sector
Own-sector index
—
—
-6.4pp
-12.7pp
-7.8pp
-15.7pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

DRREDDY daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1269.50-79.50

Relative strength

RS vs baseline · rebased to 100

DRREDDY ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
95.85-6.77

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)7,6968,0388,3818,5288,5728,8288,7537,546
↳ change QoQ—+4.4%+4.3%+1.8%+0.5%+3.0%-0.8%-13.8%
EBITDA (₹cr)2,3172,3842,4231,9982,1742,0101,888382
EBITDA margin30.1%29.7%28.9%23.4%25.4%22.8%21.6%5.1%
PAT (₹cr)1,3921,3421,4041,5871,4101,3371,190221
↳ change QoQ—-3.6%+4.6%+13.0%-11.2%-5.2%-11.0%-81.4%
Net margin18.1%16.7%16.8%18.6%16.4%15.1%13.6%2.9%
EPS (₹)83.6115.0816.9719.0916.9916.1414.502.65
D/E————————
YoY growth · Mar '26Revenue -11.5% YoYPAT -86.1% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 19 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Jun '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 18 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 16 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 May '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds DRREDDY

Mutual funds holding DRREDDY (10)

FundWeightAUM ₹crGrade
Parag Parikh Flexi Cap Reg Gr1.27%1,43,388
ICICI Prudential Large Cap Instl I Gr0.87%76,297
ICICI Prudential Large Cap Gr0.87%76,297
Nippon India Large Cap Instl Bns1.17%53,227
Nippon India Large Cap Bns1.17%53,227
Nippon India Large Cap Gr1.17%53,227
Nippon India Large Cap Dir Bns1.17%53,227
Mirae Asset Large Cap Reg Gr0.87%37,692
Bandhan Large & Mid Cap Gr0.62%17,461
UTI Large cap Reg Gr0.92%11,976

ETFs holding DRREDDY (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF8.94%
Aditya BSL Nifty Healthcare ETF7.66%
DSP Nifty Healthcare ETF7.66%
Axis NIFTY Healthcare ETF7.66%
ICICI Pru Nifty Healthcare ETF7.60%
Mirae Asset Nifty 500 Healthcare ETF6.30%
Motilal Oswal BSE Healthcare ETF5.39%
Groww Nifty 500 Low Volatility 50 ETF3.40%
Nippon India BSE Sensex Next 30 ETF3.18%
DSP BSE Sensex Next 30 ETF3.07%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma